Dr. Gomberg-Maitland has extensive experience in clinical research. She received her undergraduate degree from Yale University, her medical degree from Albert Einstein College of Medicine of Yeshiva University, and her MSc in Clinical Epidemiology from Harvard T.H. Chan School of Public Health. She completed her residency in Internal Medicine at New York Presbyterian Hospital, Weill-Cornell Medical Center and her fellowship in Cardiovascular Diseases at The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center. Currently Dr. Gomberg-Maitland is a Professor of Medicine and Director of the Pulmonary Hypertension Program at George Washington in addition to her role as the Chief Clinical Research Officer.
Dr. Gomberg-Maitland is an active leader in several national and international professional societies. She is on the Board of Directors for the International Society of Heart and Lung Transplant and a member of their Executive Finance Committee and is a Past Chair of the Education Committee of the PHA’s Scientific Leadership Council. She participated as a member of the Advisory Panel on Rare Diseases for the Patient-Centered Outcomes Research Institute (PCORI).
Dr. Gomberg-Maitland is an Editor of the Pulmonary Hypertension Section for the Journal of the American College of Cardiology and Associate Editor for multiple medical journals including CHEST and the European Respiratory Journal. With over 140 peer-reviewed manuscripts in top tier journals, Dr. Gomberg-Maitland’s interests include the epidemiology of pulmonary hypertension and the development of novel therapeutics and biomarkers. She serves as a consultant to both the FDA and the National Heart, Lung, and Blood Institute and as a member of multiple steering committees for pulmonary hypertension international drug trials.